Latest period
$56.3B
YoY change
+0.0%
5Y CAGR
-2.9%
Peak year (FY2017)
$70.3B
Latest annual
$59B
Total Assets history chart for Gilead Sciences (GILD) from 2016 to 2025
Latest: $59B
Total Assets growth chart for Gilead Sciences (GILD) from 2016 to 2025
Latest: +0.0%
Total Assets history table for Gilead Sciences (GILD) from 1991 to 2025
| FY2025 | $59B | +0.0% | +$28M | ||
| FY2024 | $59B | -5.0% | -$3.13B | ||
| FY2023 | $62.1B | -1.7% | -$1.05B | ||
| FY2022 | $63.2B | -7.0% | -$4.78B | ||
| FY2021 | $68B | -0.7% | -$455M | ||
| FY2020 | $68.4B | +11.0% | +$6.78B | ||
| FY2019 | $61.6B | -3.2% | -$2.05B | ||
| FY2018 | $63.7B | -9.4% | -$6.61B | ||
| FY2017 | $70.3B | +23.4% | +$13.3B | ||
| FY2016 | $57B | +10.2% | +$5.26B | ||
| FY2015 | $51.7B | +49.2% | +$17.1B | ||
| FY2014 | $34.7B | +53.5% | +$12.1B | ||
| FY2013 | $22.6B | +6.3% | +$1.34B | ||
| FY2012 | $21.2B | +22.8% | +$3.94B | ||
| FY2011 | $17.3B | +49.3% | +$5.71B | ||
| FY2010 | $11.6B | +19.5% | +$1.89B | ||
| FY2009 | $9.7B | +39.8% | +$2.76B | ||
| FY2008 | $6.94B | +18.9% | +$1.1B | ||
| FY2007 | $5.83B | +42.8% | +$1.75B | ||
| FY2006 | $4.09B | +8.5% | +$320M | ||
| FY2005 | $3.77B | +74.7% | +$1.61B | ||
| FY2004 | $2.16B | +38.7% | +$601M | ||
| FY2003 | $1.55B | +20.7% | +$267M | ||
| FY2002 | $1.29B | +62.1% | +$493M | ||
| FY2001 | $795M | +17.2% | +$117M | ||
| FY2000 | $678M | +55.2% | +$241M | ||
| FY1999 | $437M | -10.5% | -$51M | ||
| FY1998 | $488M | +38.5% | +$136M | ||
| FY1997 | $352M | +13.3% | +$41.4M | ||
| FY1996 | $311M | +86.4% | +$144M | ||
| FY1995 | $167M | +62.8% | +$64.3M | ||
| FY1994 | $102M | — | — | ||
| FY1992 | $147M | +35.1% | +$38.1M | ||
| FY1991 | $109M | +769.6% | +$96.2M | ||
| FY1990 | $12.5M | — | — |
- FY2025$59B+0.0%
- FY2024$59B-5.0%
- FY2023$62.1B-1.7%
- FY2022$63.2B-7.0%
- FY2021$68B-0.7%
- FY2020$68.4B+11.0%
- FY2019$61.6B-3.2%
- FY2018$63.7B-9.4%
- FY2017$70.3B+23.4%
- FY2016$57B+10.2%
- FY2015$51.7B+49.2%
- FY2014$34.7B+53.5%
- FY2013$22.6B+6.3%
- FY2012$21.2B+22.8%
- FY2011$17.3B+49.3%
- FY2010$11.6B+19.5%
- FY2009$9.7B+39.8%
- FY2008$6.94B+18.9%
- FY2007$5.83B+42.8%
- FY2006$4.09B+8.5%
- FY2005$3.77B+74.7%
- FY2004$2.16B+38.7%
- FY2003$1.55B+20.7%
- FY2002$1.29B+62.1%
- FY2001$795M+17.2%
- FY2000$678M+55.2%
- FY1999$437M-10.5%
- FY1998$488M+38.5%
- FY1997$352M+13.3%
- FY1996$311M+86.4%
- FY1995$167M+62.8%
- FY1994$102M—
- FY1992$147M+35.1%
- FY1991$109M+769.6%
- FY1990$12.5M—
Total Assets values are taken from Gilead Sciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported total assets is $56.3B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Gilead Sciences (GILD) total assets totalled $59B – edged up 0.0% year-over-year.
Over 2020–2025 (5 years), Gilead Sciences total assets expanded at a -2.9% compound annual rate, with a net decline across the window.
Gilead Sciences total assets declined from $70.3B in 2017 to $59B in 2025, a 16.0% drawdown.
Across the available history, total assets reached its high of $70.3B in 2017 and its low of $12.5M in 1990.
Gilead Sciences Total Assets by Year
Gilead Sciences Total Assets 2025: $59B
Gilead Sciences posted total assets of $59B in 2025, edged up 0.0% from 2024.
Gilead Sciences Total Assets 2024: $59B
In 2024, Gilead Sciences reported total assets of $59B, declined 5.0% below 2023.
Gilead Sciences Total Assets 2023: $62.1B
Gilead Sciences total assets in 2023 was $62.1B, edged down 1.7% below 2022.
Gilead Sciences Total Assets 2022: $63.2B
2022's total assets for Gilead Sciences came in at $63.2B, declined 7.0% below 2021.
Gilead Sciences Total Assets 2021: $68B
Gilead Sciences total assets in 2021 was $68B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Total Assets
Healthcare peers of Gilead Sciences (GILD), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on GILD
Market Cap — 10 rounds, every one of them GILD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.93% TTM
- Dividend Profile2.43% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.